292 related articles for article (PubMed ID: 31962292)
21. Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate.
Suvarna S; Das U; Kc S; Mishra S; Sudarshan M; Saha KD; Dey S; Chakraborty A; Narayana Y
PLoS One; 2017; 12(6):e0178202. PubMed ID: 28582426
[TBL] [Abstract][Full Text] [Related]
22. Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.
Zhu S; Jiang X; Boudreau MD; Feng G; Miao Y; Dong S; Wu H; Zeng M; Yin JJ
J Nanobiotechnology; 2018 Nov; 16(1):86. PubMed ID: 30384844
[TBL] [Abstract][Full Text] [Related]
23. In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells.
Choi SY; Jeong S; Jang SH; Park J; Park JH; Ock KS; Lee SY; Joo SW
Toxicol In Vitro; 2012 Mar; 26(2):229-37. PubMed ID: 22178767
[TBL] [Abstract][Full Text] [Related]
24. Polyvinylpyrrolidone-coated gold nanoparticles inhibit endothelial cell viability, proliferation, and ERK1/2 phosphorylation and reduce the magnitude of endothelial-independent dilator responses in isolated aortic vessels.
Mohamed T; Matou-Nasri S; Farooq A; Whitehead D; Azzawi M
Int J Nanomedicine; 2017; 12():8813-8830. PubMed ID: 29263670
[TBL] [Abstract][Full Text] [Related]
25. In vitro toxicity and internalization of gold nanoparticles (AuNPs) in human epithelial colorectal adenocarcinoma (Caco-2) cells and the human skin keratinocyte (HaCaT) cells.
Magogotya M; Vetten M; Roux-van der Merwe MP; Badenhorst J; Gulumian M
Mutat Res Genet Toxicol Environ Mutagen; 2022; 883-884():503556. PubMed ID: 36462792
[TBL] [Abstract][Full Text] [Related]
26. Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin.
Cho HJ; Oh J; Choo MK; Ha JI; Park Y; Maeng HJ
Int J Biol Macromol; 2014 Feb; 63():15-20. PubMed ID: 24444886
[TBL] [Abstract][Full Text] [Related]
27. From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays.
George JM; Magogotya M; Vetten MA; Buys AV; Gulumian M
Toxicol Sci; 2017 Mar; 156(1):149-166. PubMed ID: 28108664
[TBL] [Abstract][Full Text] [Related]
28. Gold Nanoparticles Induce Oxidative Stress and Apoptosis in Human Kidney Cells.
Enea M; Pereira E; de Almeida MP; Araújo AM; de Lourdes Bastos M; Carmo H
Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32455923
[TBL] [Abstract][Full Text] [Related]
29. Influence of PEG coating on the oral bioavailability of gold nanoparticles in rats.
Alalaiwe A; Roberts G; Carpinone P; Munson J; Roberts S
Drug Deliv; 2017 Nov; 24(1):591-598. PubMed ID: 28222611
[TBL] [Abstract][Full Text] [Related]
30. Self-healable and reversible liposome leakage by citrate-capped gold nanoparticles: probing the initial adsorption/desorption induced lipid phase transition.
Wang F; Liu J
Nanoscale; 2015 Oct; 7(38):15599-604. PubMed ID: 26372064
[TBL] [Abstract][Full Text] [Related]
31. Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles.
Xia Q; Huang J; Feng Q; Chen X; Liu X; Li X; Zhang T; Xiao S; Li H; Zhong Z; Xiao K
Int J Nanomedicine; 2019; 14():6957-6970. PubMed ID: 32021157
[TBL] [Abstract][Full Text] [Related]
32. In vivo testing of gold nanoparticles using the Caenorhabditis elegans model organism.
Gonzalez-Moragas L; Berto P; Vilches C; Quidant R; Kolovou A; Santarella-Mellwig R; Schwab Y; Stürzenbaum S; Roig A; Laromaine A
Acta Biomater; 2017 Apr; 53():598-609. PubMed ID: 28161575
[TBL] [Abstract][Full Text] [Related]
33. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution.
Sun YN; Wang CD; Zhang XM; Ren L; Tian XH
J Nanosci Nanotechnol; 2011 Feb; 11(2):1210-6. PubMed ID: 21456161
[TBL] [Abstract][Full Text] [Related]
34. Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential.
Steckiewicz KP; Barcinska E; Malankowska A; Zauszkiewicz-Pawlak A; Nowaczyk G; Zaleska-Medynska A; Inkielewicz-Stepniak I
J Mater Sci Mater Med; 2019 Feb; 30(2):22. PubMed ID: 30747353
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of Tumor Targeting and In Vivo Biodistribution of
El-Safoury DM; Ibrahim AB; El-Setouhy DA; Khowessah OM; Motaleb MA; Sakr TM
J Pharm Sci; 2021 Aug; 110(8):2955-2965. PubMed ID: 33812886
[TBL] [Abstract][Full Text] [Related]
36. Ultrastable-Stealth Large Gold Nanoparticles with DNA Directed Biological Functionality.
Heo JH; Kim KI; Cho HH; Lee JW; Lee BS; Yoon S; Park KJ; Lee S; Kim J; Whang D; Lee JH
Langmuir; 2015 Dec; 31(51):13773-82. PubMed ID: 26638691
[TBL] [Abstract][Full Text] [Related]
37. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
38. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration.
Fraga S; Brandão A; Soares ME; Morais T; Duarte JA; Pereira L; Soares L; Neves C; Pereira E; Bastos Mde L; Carmo H
Nanomedicine; 2014 Nov; 10(8):1757-66. PubMed ID: 24941462
[TBL] [Abstract][Full Text] [Related]
39. Particle uptake efficiency is significantly affected by type of capping agent and cell line.
Zhang F; Durham P; Sayes CM; Lau BL; Bruce ED
J Appl Toxicol; 2015 Oct; 35(10):1114-21. PubMed ID: 25809700
[TBL] [Abstract][Full Text] [Related]
40. The selective detection of Fe
Meng X; Lei B; Qi N; Wang B
Anal Biochem; 2022 Jan; 637():114453. PubMed ID: 34785195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
